×

Built a global digital presence from zero

Medicilon is a global CRO with $500M+ in revenue and 4,000 employees. Their English-language website was getting fewer than 1 visitor per day. This CRO website case study is about building a global digital presence from nothing.

A $500M company with a website getting less traffic than a personal blog.

Medicilon's previous English-language site was functionally invisible. In the five months before launch, the entire site generated 122 page views from 41 users. That's roughly 24 views per month. No organic discoverability. No working conversion infrastructure — 1 form submission total in 5 months. No content strategy for the English-speaking market.

For a Shanghai-headquartered company serving pharma and biotech worldwide, the English-language web presence simply wasn't functioning as a business tool.

The old site had 37 scroll events in 5 months. Nobody was reading. Nobody was engaging. The entire English-speaking market had no front door to Medicilon.

From invisible to 20,000+ users.

804
Conversion Events
From 1. In the same timeframe.
20,457
Active Users
Up from 41. (+49,795%)
35,622
Page Views
Up from 122. (+29,098%)
130+
Daily Visitors
Up from less than 1 per day.

This isn't a redesign. It's a new digital presence.

Same 5-month windows. March 2025 excluded as transition month.

Before (Oct 2024–Feb 2025)
Page views: 122
Active users: 41
Form submissions: 1
Scroll events: 37
Pages generating traffic: 27
After (Apr–Sep 2025)
Page views: 35,622
Active users: 20,457
Form submissions: 708
Scroll events: 9,324
Pages generating traffic: 1,398

Visitors are evaluating Medicilon as a partner.

Traffic alone means nothing without engagement. When visitors spend 40–55 seconds on service pages, they're not bouncing — they're reading technical capabilities and deciding whether to reach out.

54s
ADME/DMPK Page
Deep technical evaluation
49s
CMC Development
Service capability review
42s
Safety Assessment
Partner evaluation behavior
Technical content works when it's structured for discovery. Medicilon sells drug discovery, ADME/DMPK, and preclinical safety services — and visitors are spending nearly a minute on these pages. That's evaluation, not browsing.

The old site generated 1 form submission in 5 months. The new site generated 804 conversion events.

This isn't optimization — it's creation. The conversion infrastructure simply didn't exist before.

708
Form Submissions From 1 total on the old site. 536 form starts → 708 submits shows strong completion rates — people who engage with forms are following through.
83
Contact Page Conversion Events 23 contact form completions + 65 contact page submissions. The site is actively generating leads for Medicilon's business development team.
2.9%
Contact Page Conversion Rate 3,067 views, 83 key events. Roughly 1 in 34 contact page visitors takes action. For a B2B CRO selling six-figure+ research partnerships, that's a strong signal.

From 27 pages generating traffic to 1,398.

The redesigned site doesn't just look better — it surfaces Medicilon's capabilities through thoughtful content architecture. Every service area, technology platform, and therapeutic model now has its own discoverable page.

Page Views Users Avg Engagement
Homepage 10,346 7,260 20s
Resources Hub 3,757 3,052 12s
About 3,575 1,877 42s
Contact 3,067 2,879 5s
Drug Discovery 1,145 846 39s
CMC Development 522 368 49s
ADME/DMPK 288 205 54s
Safety Assessment 286 224 42s
The Resources page drew 3,757 views. Service pages hold visitors for 40–55 seconds. The content architecture is guiding visitors from general interest through to specific capability evaluation.

What worked — and what to watch.

We don't cherry-pick. Here's the full picture.

What Worked

From non-existent to real business tool

804 conversion events in 5 months from a site that generated 1 form submission before. This isn't improvement — it's creation.

Service page engagement

40–55 second averages on ADME/DMPK, CMC Development, and Safety Assessment pages. Visitors are evaluating Medicilon as a potential partner.

Content architecture at scale

1,398 unique pages generating traffic (up from 27). Every service area, model type, and technology platform now has a discoverable home.

Contact page conversion rate

2.9% conversion rate is healthy for B2B scientific services selling complex, six-figure+ research partnerships.

What to Watch

"From zero" attribution

The old site wasn't generating any conversions, so ROI is "from zero to something" rather than "X% improvement." The numbers are real — but context matters.

Gated asset downloads are low

Only 3 downloads in 5 months despite 3,757 resource page views. Opportunity to build more downloadable content that captures leads earlier in the funnel.

Legacy URL cleanup

Hundreds of legacy /2016xxx/ and /2017xxx/ paths still exist. Cleaning these up could improve crawl efficiency and consolidate SEO equity.

No SEO partner data yet

This analysis is GA4 behavioral data only. Adding Huckleberry for keyword rankings and organic search attribution would complete the picture.

Is your English-language website actually working for your global business?

If your company operates globally but your website only serves one market — you're leaving an entire audience without a front door. That's not a design problem. It's a revenue problem.

Start a Project
Pre-launch: Oct 1, 2024 – Feb 28, 2025 (5 months). Post-launch: Apr 1 – Sep 1, 2025 (5 months). March 2025 excluded as transition month.
Data source: Google Analytics 4 — Medicilon WP Site.
No paid search or SEO partner data included in this analysis — behavioral data only.
Conversion tracking reflects all measurable form submissions and contact events.

Prepared by Wizardly · wizardly.co

See the work behind the numbers.

The results don’t happen without great design. Take a look at the visuals we created for Medicilon during this project.

Recent Resources